The Cancer Immunotherapy Consortium engages in collaborative relationships with a number of other international organizations and associations committed to advancing immunotherapy for cancer. We seek to work with our partners to facilitate discussion among the broader cancer immunotherapy community. From these collaborative efforts come thought-leading documents that provide insight into the issues and challenges facing the field as well as practical solutions to these challenges.